The resulting strategy families correspond to major design objectives: improving pharmacokinetics and biodistribution [33, 37, 53, 66, 67], modulating vascular access and perfusion [11, 12, 15, 68, 69], normalizing or reprogramming stromal barriers [13, 17, 30, 32, 34, 70], enabling endogenous TME-responsive release or activation [46,47,48], reshaping antitumor immunity [29, 35, 71], and integrating imaging with therapeutic intervention [72,73,74]
While a healthy lifestyle remains the foundation of long-term wellness, advances in peptide therapy have introduced new approaches that may support healthy aging and cellular function
GarganoMLvan GriensvenLJIsikhuemhenOSLindequistUVenturellaGWasserSPet al
Our team ensures a comfortable and safe experience during your visit